Metformin decreases bacterial trimethylamine production and trimethylamine N-oxide levels in db/db mice

The current study aimed to explore whether metformin, the most widely prescribed oral medication for the treatment of type 2 diabetes, alters plasma levels of cardiometabolic disease-related metabolite trimethylamine N-oxide (TMAO) in db/db mice with type 2 diabetes. TMAO plasma concentration was up...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Sci Rep
Egile Nagusiak: Kuka, Janis, Videja, Melita, Makrecka-Kuka, Marina, Liepins, Janis, Grinberga, Solveiga, Sevostjanovs, Eduards, Vilks, Karlis, Liepinsh, Edgars, Dambrova, Maija
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group UK 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7471276/
https://ncbi.nlm.nih.gov/pubmed/32884086
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-71470-4
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak